Very few human lung adenocarcinoma cell lines with wild-type TP53 were capable of AIG, however three cell lines that were permissive were more sensitive to BUB1B knockdown compared to those harboring TP53 alterations (Figure 1G). The gene discussed is TP53; the disease is lung adenocarcinoma.